Nintedanib and Calcium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nintedanib (nintedanib) and Calcium (calcium). Common drug interactions include pneumonia among females and bladder cancer among males.

The phase IV clinical study analyzes what interactions people have when they take Nintedanib and Calcium. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Nintedanib?

Nintedanib has active ingredients of nintedanib. eHealthMe is studying from 1,514 Nintedanib users. Check the latest studies of Nintedanib.

What is Calcium?

Calcium has active ingredients of calcium. It is often used in osteoporosis. eHealthMe is studying from 184,201 Calcium users. Check the latest studies of Calcium.

On Jul, 30, 2026

16 people who take Nintedanib and Calcium together, and have interactions are studied.

Nintedanib and Calcium drug interactions.

What are the common drug interactions of Nintedanib and Calcium, by gender? *:

female:

Pneumonia
Colitis (inflammation of colon)
Diarrhoea
Hypokalaemia (low potassium)
Intestinal pseudo-obstruction (syndrome caused by severe impairment in the ability of the intestines to push food through)
Nausea (feeling of having an urge to vomit)
Vomiting
Blood pressure fluctuation
Blood pressure systolic increased
Bone disorder

male:

Bladder cancer
Hypertension (high blood pressure)
Joint range of motion decreased (disease of joint movement)
Joint swelling
Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
Neutropenia (an abnormally low number of neutrophils)
Pulmonary function test decreased
Renal impairment (severely reduced kidney function)
Transplant rejection (a transplant material is not worked)
Weight decreased

What are the common drug interactions of Nintedanib and Calcium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Weight decreased

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Hepatic failure (liver failure)

60+:

Pneumonia
Colitis (inflammation of colon)
Bone disorder
Gait disturbance
Hypertension (high blood pressure)
Muscle injury
Pain
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Death
Diffuse alveolar damage (common manifestation of drug-induced lung injury)

What are the existing conditions these people have? *

Idiopathic Pulmonary Fibrosis (chronic lung disease): 5 people, 31.25%
Constipation: 3 people, 18.75%
Interstitial Lung Disease: 2 people, 12.50%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 12.50%
Microscopic Polyangiitis (inflammation involving multiple blood or lymph small-vessel): 2 people, 12.50%
High Blood Pressure: 2 people, 12.50%
Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder): 1 person, 6.25%
Depression: 1 person, 6.25%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 6.25%
Gastrointestinal Pain: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Nintedanib and Calcium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously